Physician profile
Herman Hasselkus
NPI 1053481382
$21,858.89
in general payments reported to CMS, 2019-2025
55 companies · $3,882 in 2025
The $3,882 reported for 2025 was more than what 97% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,674 · 2020: $1,420 · 2021: $2,619 · 2022: $2,959 · 2023: $3,383 · 2024: $3,922 · 2025: $3,882.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,167.26 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $4,250.73 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Abbvie INC. | $2,602.30 | 2019-2025 | |
| Amgen INC. | $2,590.39 | 2019-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $1,625.60 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Janssen Pharmaceuticals, INC | $1,033.06 | 2019-2025 | Spravato |
| Lilly USA, LLC | $989.46 | 2019-2025 | Mounjaro, Trulicity, Zepbound |
| Novartis Pharmaceuticals Corporation | $809.68 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $800.90 | 2021-2025 | |
| Titan Pharmaceuticals, INC. | $582.21 | 2019 | |
| Pfizer INC. | $522.02 | 2019-2025 | |
| Esperion Therapeutics, INC. | $516.79 | 2020-2025 | Nexletol |
| Sanofi-Aventis U.S. LLC | $498.95 | 2019-2024 | |
| Madrigal Pharmaceuticals | $486.94 | 2024-2025 | Rezdiffra, Resmetirom |
| Allergan, INC. | $409.52 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $366.77 | 2019-2023 | Belsomra, Steglatro |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Herman Hasselkus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.